e-learning
resources
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD
Sara Roversi, Roberto Tonelli, Bianca Beghè, Federico Banchelli, Roberto D'Amico, Mario Malerba, Leonardo M. Fabbri, Enrico M. Clini
Source:
ERJ Open Res, 4 (3) 00087-2018; 10.1183/23120541.00087-2018
Journal Issue:
July
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sara Roversi, Roberto Tonelli, Bianca Beghè, Federico Banchelli, Roberto D'Amico, Mario Malerba, Leonardo M. Fabbri, Enrico M. Clini. Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD. ERJ Open Res, 4 (3) 00087-2018; 10.1183/23120541.00087-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Cost analysis for inpatient therapy in elderly patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 661s
Year: 2004
Polypharmacy in patients hospitalised for acute exacerbation of COPD
Source: Eur Respir J 2014; 44: 791-794
Year: 2014
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations
Source: Eur Respir J, 53 (4) 1900147; 10.1183/13993003.00147-2019
Year: 2019
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Polypharmacy in patients with acute exacerbation of COPD
Source: Annual Congress 2011 - COPD management
Year: 2011
Outpatient care for reducing readmissions of patients hospitalized for exacerbation of COPD
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Role of aerosolized therapy in the incidence of cardiac rythm disturbances in patients hospitalized with a COPD exacerbation
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Statins and outcome of COPD patients after hospitalization for COPD exacerbations
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010
CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions
Source: Eur Respir J, 53 (5) 1802014; 10.1183/13993003.02014-2018
Year: 2019
Early rehabilitation in COPD patients admitted for acute exacerbation
Source: ISSN=ISSN 1810-6838, ISBN=, page=245
Year: 2005
The rationality of the use of NIV in elderly patients with acute COPD exacerbation
Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure
Year: 2018
Impact of diabetes in patients admitted with acute exacerbation of COPD
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Predicting mortality in patients hospitalised with acute exacerbations of COPD (AECOPD) requiring assisted ventilation
Source: Annual Congress 2012 - New scientific findings on noninvasive ventilation in the acute setting
Year: 2012
COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016
Prognosis after hospitalization for acute exacerbations of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001
Feasibility and benefits of an innovative airway clearance device in COPD patients hospitalized for acute exacerbation
Source: Virtual Congress 2020 – New insights into determinants of patient-reported outcomes in chronic respiratory diseases
Year: 2020
C-reactive protein at discharge, diabetes mellitus and ≥1 prior hospitalization predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
Predictors of exacerbations requiring hospitalisation in patients with stable COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 177s
Year: 2006
Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD.
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept